文献

J-GLOBAL ID：202002261965224512   整理番号：20A2301181

非転移性去勢抵抗性前立腺癌に対するアパルタミド,エンザルタミド,ダロルタミド:系統的レビューとネットワークメタ解析

Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

著者 (26件)： Mori Keiichiro (Department of Urology, Medical University of Vienna, Vienna, Austria) ,  Mori Keiichiro (Department of Urology, The Jikei University School of Medicine, Tokyo, Japan) ,  Mostafaei Hadi (Department of Urology, Medical University of Vienna, Vienna, Austria) ,  Mostafaei Hadi (Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran) ,  Pradere Benjamin (Department of Urology, Medical University of Vienna, Vienna, Austria) ,  Pradere Benjamin (Deaprtment of Urology, PRES Centre Val de Loire, CHRU Tours, France, Universite Francois Rabelais de Tours, Tours, France) ,  Motlagh Reza Sari (Department of Urology, Medical University of Vienna, Vienna, Austria) ,  Quhal Fahad (Department of Urology, Medical University of Vienna, Vienna, Austria) ,  Quhal Fahad (Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia) ,  Laukhtina Ekaterina (Department of Urology, Medical University of Vienna, Vienna, Austria) ,  Laukhtina Ekaterina (Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia) ,  Schuettfort Victor M. (Department of Urology, Medical University of Vienna, Vienna, Austria) ,  Schuettfort Victor M. (Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany) ,  Abufaraj Mohammad (Department of Urology, Medical University of Vienna, Vienna, Austria) ,  Abufaraj Mohammad (Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan) ,  Karakiewicz Pierre I. (Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada) ,  Kimura Takahiro (Department of Urology, The Jikei University School of Medicine, Tokyo, Japan) ,  Egawa Shin (Department of Urology, The Jikei University School of Medicine, Tokyo, Japan) ,  Shariat Shahrokh F. (Department of Urology, Medical University of Vienna, Vienna, Austria) ,  Shariat Shahrokh F. (Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia) ,  Shariat Shahrokh F. (Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan) ,  Shariat Shahrokh F. (Department of Urology, Weill Cornell Medical College, New York, NY, USA) ,  Shariat Shahrokh F. (Department of Urology, University of Texas Southwestern, Dallas, TX, USA) ,  Shariat Shahrokh F. (Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria) ,  Shariat Shahrokh F. (Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic) ,  Shariat Shahrokh F. (European Association of Urology Research Foundation, Arnhem, Netherlands)
資料名： International Journal of Clinical Oncology (Web)  (International Journal of Clinical Oncology (Web))
巻： 25  号： 11  ページ： 1892-1900  発行年： 2020年 
JST資料番号： U1599A  ISSN： 1341-9625  資料種別： 逐次刊行物 (A)
記事区分： 文献レビュー  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 抄録:非転移性去勢抵抗性前立腺癌(nmCRPC)の管理は,す...

シソーラス用語： ヒト ,...
準シソーラス用語： *アンドロゲン受容体拮抗薬 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2301181&from=J-GLOBAL&jstjournalNo=U1599A") }}

著者キーワード (5件)： 非転移性去勢抵抗性前立腺癌 ,  ネットワークメタ分析 ,  アパルタミド ,  ダロルタミド ,  エンザルタミド

分類 (3件)： 泌尿生殖器の腫よう  (GM04000S) ,  腫ようの薬物療法  (GE03032C) ,  抗腫よう薬の臨床への応用  (GW16020L)

物質索引 (3件)： アパルタミド ,  エンザルタミド ,  ダロルタミド

タイトルに関連する用語 (6件)： 非転移性去勢抵抗性前立腺癌 ,  アパルタミド ,  エンザルタミド ,  ダロルタミド ,  系統的レビュー ,  メタ解析